3069MO Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC)
作者
Michiel S. van der Heijden,Thomas B. Powles,Matthew D. Galsky,James W.F. Catto,Joshua J. Meeks,Ruslan Aleksandrovich Zukov,K. Izumi,Kuo‐Hung Huang,Muhammet Bekir Hacıoğlu,S.A. Hussain,A. Necchi,Herlinde Dumez,Marco Julius Schnabel,Pierre Bigot,Angela Estay,A.G.A. Lui,Clara Ceriani Cernadas,K. Bigos,Stephan Hois,H. Nishiyama
出处
期刊：Annals of Oncology [Elsevier BV] 日期：2025-09-01卷期号：36: S1483-S1483被引量：1
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
学术雷锋
null
北白川anko
aaaa
DW
秋风
坚强冰枫
乐空思
渡人舟
吃葡萄不吐葡萄皮
v0id
Criminology34
飘逸的大雁
散逸层梦游
Mm11
牧青
Elsevier大王
OK
滴滴答答
皖公网安备34019202002308
